A cystic fibrosis patient is calling for a medicine to be made available on the NHS as she fears she may otherwise have to leave her island home.
Hannah McDiarmid, 23, who lives on Skye, currently has to make a three-hour each way trip to Raigmore Hospital in Inverness every other month for treatment.
When she develops an infection, a frequent hazard for those with cystic fibrosis, she stays there as an inpatient for a fortnight at a time while she undergoes intensive IV antibiotic treatment.
She is considering moving from the island where her family has lived for six generations as the long journeys are taking their toll.
However she believes if the drug Orkambi were available on the NHS it could benefit fellow sufferers across Scotland and save her from having to move.
She is backing Cystic Fibrosis Trust's campaign for better access to medicines ahead of a debate in the Scottish Parliament on Tuesday evening.
Ms McDiarmid said: "I love Skye and one part of my family has always lived here.
"I studied Gaelic on the island and work part-time here at the archive centre and at Visit Scotland as the area is so important to me, but the journey is such a strain on us all.
"Medical research is really changing the way cystic fibrosis can now be treated and there is a medicine called Orkambi that could potentially help me.
"I just wish this was available on the NHS as it could make my life easier and could potentially mean I could remain on Skye with my family rather than have to live closer to the hospital."
Cystic fibrosis is a debilitating life-shortening illness that creates a build-up of thick, sticky mucus that causes chronic lung infections and progressive lung damage.
Ms McDiarmid, who was diagnosed with the condition when she was 17 weeks old, has previously undergone operations for polyps in her nose, suffers stomach problems, has chronic fatigue and most recently has been coughing up blood due to haemoptysis.
The Cystic Fibrosis Trust said Orkambi is a precision medicine that could benefit more than 330 people in Scotland.
The trust said while Orkambi is not a cure, it has been found to slow decline in lung function - the most common cause of death for people with cystic fibrosis.
West Scotland MSP Maurice Corry said: "It's a drug that could have such a great impact on the patients that need it and the Scottish Government need to make sure it is available for patients on the NHS."
A Scottish Government spokesman said: "Talks between Vertex Pharmaceuticals and NHS National Procurement are ongoing and we continue to encourage Vertex to submit a fresh application for Orkambi to the Scottish Medicines Consortium (SMC) at a price that is fair.
"Decisions made by the SMC are independent of Ministers and Parliament. However, we have significantly improved access to new medicines in recent years as a result of our investment and reforms.
"These include the introduction of a new system for doctors, on behalf of individual patients, to access licensed treatments not yet generally available on the NHS in Scotland."
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereLast Updated:
Report this comment Cancel